Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
24 Cards in this Set
- Front
- Back
HPV high risk subtypes
|
16, 18, 45, 31 , 33
|
|
Cervical dysplasia transit time if neglected
|
– CIN 1 is 5 years
– CIN 2 is 3 years – CIN 3 is 1 year |
|
After satisfactory colposcopy for CIN I
|
– If tx selected, excisional preferred
– Test for HPV at 12 mos OR do 2 repeat paps at 6 and 12 mos – If repeat ASC or more OR high risk HPV refer back to colpo |
|
After unsatisfactory colpo for CIN I
|
– Dx excisional procedure (not ablative)
– In pregnant, adolescent, immunosuppressed women may be followed as above |
|
After satisfactory colposcopy for CIN II & III
|
Excisional or ablative therapy that removes the entire transformational zone
|
|
After unsatisfactory colposcopy for CIN II & III
|
– do dx excisional conization
– up to 7% will have occult invasive cervical carcinoma – Margins are risk factor for recurrence/persistent |
|
Cervical dysplasia in pregnancy
|
– Follow with Pap/colposcopy each trimester
– Bx if suspect cancer – Plan treatment 6 weeks postpartum |
|
Tx for cervical carcenoma
|
– Stage I is Surgery or Simple hysterectomy
– Stage II is Surgery or Radical Hysterectomy (take LN’s and part of vagina) – Stage III and IV is Radiation |
|
False (-) pap
|
– Too few abnormal cells
– smears w/ obscuring inflamm or blood limiting evaluation |
|
What defines a satisfactory pap
|
– in conventional, ³10% of slide has cells
– Thin preps, 5000 cells – Epi or glandular abnormality even if there are less than adequate numbers of cells |
|
What defines an unsatisfactory pap
|
– Specimen rejected (Improper pt identifiers, Slides received broken)
- Too few squamous cells - poor preservation - Totally obscured by blood |
|
(-) for Intraepithelial Lesion or Malignancy pap classification
|
– benign cellular changes
– Endometrial cells if >40 yrs (May indicate an endometrial lesion like hyperplasia, carcinoma) |
|
Condyloma (Koilocytes) histo
|
– Pathgnomonic for HPV (LGSIL in Bethesda)
– Clear cyto, well defined vacuole w/ enlarged, irregular and dark nucleus (binucleation common) |
|
SC in situ histo
|
3D aggregates of cells w/ little cytoplasm and dark irregular nuclei
|
|
Cervical invasive SCC histo
|
– irregular chromatin clumping, prominent nucleoli
– Background may be necrotic |
|
ASCUS histo
|
– Nuclear enlargement but no hyerchromasia
– Cytoplasmic vacuolization without nuclear abnormalities of HPV – Inflammation induced nuclear enlargement |
|
ASC-H histo
|
– Small cells with hyperchromatic nuclei too few in number for diagnosis of HSIL
– Atypical squamous metaplasia from endocervical canal |
|
AGUS histo
|
– Nuclear enlargement w/ minimal hyperchromasia
– Inflamm associated reactive atypia – Metaplasia w/ reactive atypia – Thick clusters of endocervical cells difficult to classify (may be related to sampling device) |
|
HPV-mediated carcinogenesis
|
– infects basal cells at
– integrates into host DNA – viral oncogenes E6 and E7 over expressed and bind – this -> destruction of proteins from p53 and Rb genes – Proliferating cells acquire additional genetic errors – Clonal selection leads to malignant phenotype |
|
Lichen sclerosus
|
– vulvar dystrophy
– may be painful, pale white plaques, cause unknown |
|
Squamous hyperplasia
|
– vulvar dystrophy
– may be pruritic and related to a wide variety of irritants |
|
Paget’s disease
|
– Glandular tumor cells w/in epidermis that stain for mucin (indicative of their glandular origin)
– Most cases are NOT associated with an underlying adenocarcinoma |
|
Nabothian cyst
|
benign mucinous cyst-like distension of endocervical glands 2o to obstruction from squamous metaplasia
|
|
Microglandular hyperplasia
|
benign prolif of endocervical glands, likely hormonally driven (P stimulation)
|